Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, +617

The Lancet Oncology

5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials +8

<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Bram De Laere, Steffi Oeyen, Markus Mayrhofer, +34

Clinical Cancer Research

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Markus Mayrhofer, Bram De Laere, Tom Whitington, +29

Genome Medicine

Model-based Iterative Reconstruction and Adaptive Statistical Iterative Reconstruction Techniques in Abdominal CT: Comparison of Image Quality in the Detection of Colorectal Liver Metastases

David Volders, Alain Bols, Marc Haspeslagh, +1

Radiology

Epidermal Growth Factor Receptor and K-RAS status in two cohorts of squamous cell carcinomas

Nancy Van Damme, Philippe Deron, Nadine Van Roy, +8

BMC Cancer

Recurrent bacteremia by Chtyseobacterium indologenes in an oncology patient with a totally implanted intravascular device

Eric Nulens, Barbara Bussels, Alain Bols, +2

Clinical Microbiology and Infection

Recurrent BacteremiaChtyseobacterium IndologenesMicrobiologyImplanted Intravascular DeviceMedicine +1

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C

Khaldoun Almhanna, David Wright, T. Macarulla Mercadé, +17

Investigational New Drugs

OncologyPancreatic CancerMedicineAntibody-drug ConjugatePathology +6

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

Kim De Leeneer, Ilse Coene, Brecht Crombez, +8

Breast Cancer Research and Treatment

Brca1 MutationBreast OncologyMedicineBrca1/2 MutationsGenetic Epidemiology +11

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

P. Pronzato, Enrico Cortesi, Carin C.D. van der Rijt, +6

The Oncologist

Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: Potential of whole tumour ROI and selective ROI analysis

Kenneth Coenegrachts, Alain Bols, Marc Haspeslagh, +1

European Journal of Radiology

EngineeringHepatologyMedical ImagingMedicineHepatobiliary Tumor +11